Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any Leber congenital amaurosis in which the cause of the disease is a mutation in the LCA5 gene.
Features include: Undetectable electroretinogram, Visual loss, Hypermetropia, and Nystagmus and 2 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 2 | Nystagmus, Visual impairment |
Age of onset: at birth.
LCA5 encodes lebercilin LCA5 (697 aa). Involved in intraflagellar protein (IFT) transport in photoreceptor cilia. Plays a role in the ciliary transport of photoreceptors outer segment proteins Highest expression in Cervix Ectocervix (8.4 TPM) and Cervix Endocervix (7.9 TPM).
Leber congenital amaurosis 5 is associated with mutations in the LCA5 gene on chromosome 6.
LCA5 is classified as a druggable target with score 0.0.
Genetic testing for LCA5 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Leber congenital amaurosis 5 has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include biologic therapy. Pipeline includes 1 PHASE1. Research is primarily industry-sponsored.
7 publications have been identified in PubMed for Leber congenital amaurosis 5. Research spans Diagnostic / Biomarker (29%), Clinical Trial Publication (29%), and Review / Meta-Analysis (14%).
Athanasiou D (2025). [PMID: 39934925](https://pubmed.ncbi.nlm.nih.gov/39934925/). *Acta neuropathologica communications*. [Gene Therapy / Novel Therapeutics]
Panneman DM (2025). [PMID: 40465261](https://pubmed.ncbi.nlm.nih.gov/40465261/). *Investigative ophthalmology & visual science*. [Review / Meta-Analysis]
Aleman TS (2025). [PMID: 40598770](https://pubmed.ncbi.nlm.nih.gov/40598770/). *Molecular therapy : the journal of the American Society of Gene Therapy*. [Clinical Trial Publication]
Upadhyaya A (2025). [PMID: 39728598](https://pubmed.ncbi.nlm.nih.gov/39728598/). *Indian journal of ophthalmology*. [Diagnostic / Biomarker]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 5:41 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about Leber congenital amaurosis 5
Zhou Y (2024). [PMID: 38662103](https://pubmed.ncbi.nlm.nih.gov/38662103/). *Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie*. [Clinical Trial Publication]
Akhtar Z (2024). [PMID: 39766915](https://pubmed.ncbi.nlm.nih.gov/39766915/). *Genes*. [Epidemiology / Natural History]
AI-curated news mentioning Leber congenital amaurosis 5
Updated Feb 18, 2026
A study identifies dual mutations in CEP290 and GLI3 in an infant presenting with Leber congenital amaurosis and postaxial polydactyly, resembling Bardet-Biedl syndrome. This research enhances understanding of genetic contributions to these rare conditions.